Clinical Trial Update: A Phase I Dose Finding Study of MB-CART2219.1 [Phase 1]

View source ↗

Summary

This clinical trial update reports that a Phase I dose-finding study of MB-CART2219.1 is currently recruiting at University Hospital Tuebingen for lymphoma, chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Lymphocytic Leukemia
• Lymphoma

Drugs mentioned

• MB-CART2219.1

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Lymphoma, CLL | Phase 1 | Status: RECRUITING